Fludarabine, cyclophosphamide, and antithymocyte globulin for a patient with dyskeratosis congenita and severe bone marrow failure.
Ostronoff
Fabiana
F
Ostronoff
Mauricio
M
Calixto
Rodolfo
R
Florêncio
Rodrigo
R
Domingues
Mariana C
MC
Souto Maior
Ana Patricia
AP
Sucupira
Alexandre
A
Tagliari
Clemente
C
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000150:complications / Q000188:drug therapy; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D019871:Dyskeratosis Congenita / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine